Article citationsMore>>

(2011) End-of-Study Safety, Immunogenicity, and Efficacy of Quadrivalent HPV (Types 6, 11, 16, 18) Recombinant Vaccine in Adult Women 24 - 45 Years of Age. British Journal of Cancer, 105, 28-37.
https://doi.org/10.1038/bjc.2011.185

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top